Understanding the Archive and Foreseeing the Future

2025.01.23
【Hisashi Iwase】 The progress of chromatography since the late 1970s has been remarkable. In the field of protein research, techniques for isolating target proteins advanced around Sephadex media, and the introduction of… 黒澤伸行

Introducing Vazyme Biotech Co., Ltd.

2025.01.05
Vazyme Biotech Co., Ltd. is a global service provider specializing in the design, manufacturing, and application of products in the field of molecular biology. The company is continuously expanding its core technology applications in life... 黒澤伸行

Introducing Avantor, Inc.

2025.01.05
Avantor, a Fortune 500 company, is a leading global provider of products and services for customers in the biopharma, healthcare, education and government, and advanced technologies and... 黒澤伸行

Introducing AtkinsRéalis Group Inc.,

2025.01.05
AtkinsRéalis is a world-leading professional services and project management company, established through numerous mergers since 1911. Our mission is to create a better future for... 黒澤伸行

Introducing RareCyte, Inc.

2025.01.05
RareCyte is an innovative, microenvironment-focused company that has developed technologies and end-to-end integrated platforms to accelerate research in oncology, ... 黒澤伸行

【Dialogue】 Exploring Data Science for the Future of Digital Healthcare

2025.01.05
In recent years, particularly over the last few years, ICT technologies have advanced rapidly, bringing significant changes to the overall structure of society.... 黒澤伸行

Issue No. 7: Baseline Research and Biomarker Exploration

2025.01.05
【Tsuguchika Kaminuma】 It is believed that it will take at least 10 years for the drugs currently under development to begin practical use. By then, the overall healthcare system surrounding drugs is expected to differ significantly... 黒澤伸行

Issue No. 6: Expectations for Drug Discovery and Health Research Using Simple Model Organisms – From the Perspective of ICT Utilization

2025.01.05
【Tsuguchika Kaminuma】 This series is based on the… 黒澤伸行

Issue No. 5: Urgent Need for Building Co-Creation Platforms and Developing ICT Talent

2025.01.06
【Tsuguchika Kaminuma】 This series is based on the recognition that “drug development is entering a major turning point,” with its main theme being how to address... 黒澤伸行

Issue No. 4: How to Navigate the Second Internet Revolution and the New Wave of Artificial Intelligence?

2025.01.09
【Tsuguchika Kaminuma】 In this series, we have been reviewing the drastic changes in the research and development environment for drug creation since around 2010... 黒澤伸行

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

2025年1月

Understanding the Archive and Foreseeing the Future

Introducing Vazyme Biotech Co., Ltd.

Introducing Avantor, Inc.

Introducing AtkinsRéalis Group Inc.,

Introducing RareCyte, Inc.

【Dialogue】 Exploring Data Science for the Future of Digital Healthcare

Issue No. 7: Baseline Research and Biomarker Exploration

Issue No. 6: Expectations for Drug Discovery and Health Research Using Simple Model Organisms – From the Perspective of ICT Utilization

Issue No. 5: Urgent Need for Building Co-Creation Platforms and Developing ICT Talent

Issue No. 4: How to Navigate the Second Internet Revolution and the New Wave of Artificial Intelligence?

最新記事

Events

2025年1月

Understanding the Archive and Foreseeing the Future

Introducing Vazyme Biotech Co., Ltd.

Introducing Avantor, Inc.

Introducing AtkinsRéalis Group Inc.,

Introducing RareCyte, Inc.

【Dialogue】 Exploring Data Science for the Future of Digital Healthcare

Issue No. 7: Baseline Research and Biomarker Exploration

Issue No. 6: Expectations for Drug Discovery and Health Research Using Simple Model Organisms – From the Perspective of ICT Utilization

Issue No. 5: Urgent Need for Building Co-Creation Platforms and Developing ICT Talent

Issue No. 4: How to Navigate the Second Internet Revolution and the New Wave of Artificial Intelligence?

最新記事

Tag Cloud

Events